Literature DB >> 22125407

Sociodemographic factors responsible for blindness in diabetic Egyptian patients.

Khaled Gamal Ibraheem Abueleinen1, Hany El-Mekawey, Yasser Sayed Saif, Amr Khafagy, Hoda Ibrahim Rizk, Eman M Eltahlawy.   

Abstract

PURPOSE: To evaluate factors behind the delay in diagnosis and treatment among Egyptian patients who present with complicated diabetic retinopathy.
METHODS: Observational cross-sectional study of diabetic patients with advanced diabetic retinopathy. Patients were asked to answer a questionnaire to assess the impact of several sociodemographic factors.
RESULTS: A total of 397 patients agreed to take the questionnaire. Diabetic vitreous hemorrhage was the most common ocular complication and was found in 359 patients (90.4%). A total of 158 (39.8%) patients knew that diabetes mellitus can be sight threatening, while 240 (60.2%) were not aware until they developed sight threatening complication. A total of 179 patients (45.1%) had early retirement because of visual loss related to diabetes mellitus. Multivariate logistic regression has shown that education, internist, contact with other patients, and media were respectively significant in predicting the awareness of patients about the sight-threatening effect of diabetic retinopathy.
CONCLUSION: Patient education regarding diabetes and diabetic eye disease is essential for early detection and compliance with treatment. Illiteracy has a significant impact on development of sight-threatening diabetic complications. The internist is the first line of prophylaxis. Media has to participate more in patient education.

Entities:  

Keywords:  blindness; education; laser photocoagulation; macular edema; vitreous hemorrhage

Year:  2011        PMID: 22125407      PMCID: PMC3218170          DOI: 10.2147/OPTH.S21765

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Diabetes mellitus is an increasing health problem that currently affects more than 150 million people worldwide and is expected to affect more than 200 million people by the year 2025.1 Diabetes mellitus is a chronic metabolic multisystem disease. Complications from diabetes can be classified as microvascular or macrovascular. Microvascular complications include system damage as diabetic peripheral neuropathy, renal nephropathy, and diabetic retinopathy. Macrovascular complications include cardiovascular disease and stroke, and peripheral vascular disease, which may lead to diabetic foot, gangrene, and amputation.2 Herman et al3 found that diabetic retinopathy accounted for about 42% of diabetic patients in Egypt; however, the study done by Macky et al4 found the incidence to be 20.5%. This improvement could be attributed to early detection of diabetic patients, with better medical care.3,4 The duration of diabetes remains the most significant predictor of visual impairment among people with type II diabetes. Visual loss in diabetic patients is often a late symptom of advanced diabetic retinopathy, with serious undesirable consequences affecting the health and vision-related quality of life.5 The progression of diabetic retinopathy can have a deleterious effect on patients, both physically and emotionally. Advanced diabetic eye disease can have a significant economic burden on the patient, family members, society, and the health care system.6 According to the recommendations of the American Academy of Ophthalmology, the first fundus examination in patients with type I diabetes mellitus should be performed 5 years after diagnosis because retinopathy rarely develops before this period. However, patients with type II diabetes mellitus should be examined immediately when they are diagnosed, because the duration of diabetes is uncertain and some degree of diabetic retinopathy may be present.7–9 Several multicenter studies have shown that if laser photocoagulation is initiated at the proper time for treatment of diabetic retinopathy, the probability of blindness is considerably reduced. Hence proper management of diabetic eye disease requires collaboration between an internist and an ophthalmologist.10–13 Furthermore, patient education regarding diabetes and diabetic eye disease is essential for compliance with treatment. The primary objective of this study is to highlight sociodemographic factors responsible for blindness caused by diabetic retinopathy among the Egyptian population.

Materials and methods

This study was conducted among a sequential sample of 397 diabetic patients with preventable or treatable retinal complications. The study included patients presented to governmental hospitals of Kasr El eini (Cairo University Hospital), Beni-Suef University Hospital, insurance clinics, Agooza and Mabarra Ministry of Health hospitals, and private clinics where the authors work. These patients represented samples from almost all health sectors in Egypt: national health insurance, ministry of health, university teaching hospitals, and the private sector. The study was conducted between February 2008 and March 2010. Inclusion criteria included patients with diabetic vitreous hemorrhage, tractional retinal detachment involving or threatening the macula, rubeosis irides, macular edema with foveal hard exudates, and cystoid or ischemic maculopathy. Exclusion criteria included all diabetic patients without the abovementioned complications and patients with peripheral stationary tractional retinal detachment. During examination of diabetic patients, those who are legally blind secondary to advanced diabetic retinopathy were asked to answer a questionnaire (Table 1). The data included age, sex, residence, educational level, duration of diabetes, duration of diabetes adjustment, type of therapy, family history of diabetes, consanguinity, smoking, associated systemic disease (eg, hypertension, nephropathy, neuropathy, cerebrovascular, myocardial infarction), associated cataract, and glaucoma. Several questions were used to assess the patient education regarding diabetic eye disease and its impact on their occupational status, laser treatment, and cost of treatment of diabetic retinopathy.
Table 1

The questionnaire

Hospital or clinic

Age

Gender

Residence: urban, rural, or suburban

Educational level

Onset of diabetes

Treatment: tablets or insulin

Controlled or not, and duration of control

Family history of diabetes

Consanguinity

Associated conditions:

Systemic:

Hypertension

Renal

Smoking even if passive or ex-smoker

Heart

Neuropathy? Foot or hand tingling and numbness

Cerebral infarction

Ocular:

Glaucoma

Cataract

Do you follow up with a physician?

Prior to visual impairment, did your physician tell you about periodic ocular check up?

Why did you consult an ophthalmologist? Regular follow up or when vision dropped

Before you met ophthalmologist, did you know that diabetes could lead to blindness?

Source of information about diabetic eye disease? Internist, ophthalmologist, patients, media, or readings

History of laser treatment?

Costs of treating diabetic retinopathy

Impact of eye condition on the patient functioning and career

Ocular condition: diabetic vitreous hemorrhage, tractional retinal detachment involving or threatening the macula, rubeosis irides, macular edema with foveal hard exudates, cystoid or ischemic maculopathy

Data analysis

Data were statistically described in terms of mean ± standard deviation (SD), frequencies (number of cases) and relative frequencies (percentages) when appropriate. Multivariate logistic regression analysis was done to test for the preferential effect of the independent variables of age, sex, residence, education, source of information about diabetic retinopathy, and the awareness of patients about the sight-threatening effect of diabetes mellitus. A probability value (P-value) less than 0.05 was considered statistically significant. All statistical calculations were done using computer programs Microsoft Excel 2003 (Microsoft Corporation, NY) and SPSS (SPSS Inc, Chicago, IL).

Results

The data were collected from these patients. As shown in Table 2, the mean age was 56 years (SD ± 8.56). The number of males was 155 (39%) and females was 242 (61%). A total of 123 (31%) reported they smoke, whereas 274 (69%) did not.
Table 2

Sociodemographic and clinical data

Sociodemographic dataMean ± SDPatient number (%)
Age, years56 (8.56)
Sex
 Male155 (39%)
 Female242 (61%)
Residence
 Urban196 (49.4%)
 Rural144 (36.3%)
 Suburban57 (14.4%)
Duration of diabetes mellitus in years16.1 (6.78)
Family history of diabetes mellitus320 (80.6%)
Consanguinity98 (24.7%)
Associated systemic disease
 Peripheral neuropathy350 (88.2%)
 Hypertension237 (59.7%)
 Cardiovascular disease64 (16.1%)
 Nephropathy23 (5.8%)
 Cerebrovascular disease (stroke)20 (5%)
Associated ocular disease
 Cataract164 (41.3%)
 POAG13 (3.3%)
 Neovascular glaucoma10 (2.5%)

Abbreviations: POAG, primary open angle glaucoma; SD, standard deviation.

There were 196 patients (49.4%) living in urban areas, 144 (36.3%) in rural and 57 (14.4%) living in suburban areas. The mean duration of diabetes mellitus was 16.1 years (SD 6.78). Family history of diabetes mellitus was positive among 320 (80.6%), whereas 77 patients (19.4%) had no family history of diabetes mellitus. Consanguinity was positive among 98 patients (24.7%). The patients’ levels of education were also recorded. Out of the 397 patients, 140 (35.3%) were found illiterate, 59 (14.9%) were able to read and write, 161 (40.6%) had some degree of education ranging from primary to high school diploma, 35 (8.8%) had a graduate university degree, and only 2 (0.5%) had postgraduate studies. Diabetic peripheral neuropathy was the most common associated systemic disorder, with tingling and parathesia symptoms recorded in 350 (88.2%) patients. Hypertension ranked second, with 237 (59.7%) patients. Cardiovascular disease such as myocardial infarction was noted in 64 (16.1%) patients. Nephropathy was reported among 23 (5.8%) patients, and 20 (5%) patients had a prior cerebrovascular accident. The most common cause of blindness was diabetic vitreous hemorrhage affecting 359 patients (90.4%). Other causes of blindness were tractional detachment (165 patients, 41.6%), cystoid macular edema or foveal hard exudates (114 patients, 28.7%), end stage diabetic retinopathy (37 patients, 9.32%), and central retinal vein occlusion (16 patients, 4%). A total of 164 (41.3%) patients had associated cataract. Glaucoma was reported in 23 patients (5.8%): 13 (3.3%) patients were noted to have primary open angle glaucoma, while 10 (2.5%) patients had neovascular glaucoma. A total of 349 (87.9%) patients reported regular follow up with an internist, whereas 48 (12.1%) did not. In our structured interview, we assessed patient education, source of information about diabetic retinopathy, and the effectiveness of the doctor–patient relationship. When questioned about diabetic retinopathy as a cause of blindness, only 158 (39.8%) patients knew that diabetes mellitus can be sight threatening, while 239 (60.2%) were not aware until they developed sight-threatening complications. Only 118 (29.7%) were informed by the internist about the necessity of dilated fundus examination. Forty-two patients (10.6%) reported that they follow up regularly with an ophthalmologist, whereas 355 (89.4%) reported that they have been to ophthalmologist only because of visual deterioration. Regarding patient education and source of information about diabetic retinopathy, 139 (35%) chose their internist, 391 (98.5%) chose their ophthalmologist, 59 (14.9%) referred to other patients, 34 (8.6%) chose media, while 14 (3.5%) acquired their knowledge on diabetic retinopathy through reading printed articles. Multivariate logistic regression in Table 3 showed that age, sex, residence, patient knowledge acquired through ophthalmologist, and reading printed articles were found insignificant, while education level (odds ratio [OR] 1.47, confidence interval [CI] 1.092–1.99, P = 0.01), internist (OR 156.1, CI 63.31–384.63, P < 0.001), contact with other patients (OR 8.51; CI 2.99–24.23; P < 0.001), and media (OR 29.96; CI 5.57–161.26; P < 0.001) had a significant impact on awareness of patients about diabetic retinopathy.
Table 3

The preferential effect of independent variables (age, sex, residence, education, role of internist, ophthalmologist, patient, and media in predicting the awareness of patients about the sight-threatening effect of diabetes mellitus

Independent variableOdds ratio95% CI for odds ratioP-value

LowerUpper
Age1.0130.9651.0640.603
Sex2.0510.7905.3260.140
Residence1.1310.6282.0380.682
Education level1.4731.0921.9870.011
Internist156.05863.318384.6320.000
Ophthalmologist0.5730.02115.9470.743
Patient8.5082.98824.2260.000
Media29.9625.567161.2570.000
Reading0.690.00111.90.998

Abbreviation: CI, confidence interval.

A total of 130 patients (32.7%) received laser treatment for diabetic retinopathy at the time of the survey. Regarding the impact of diabetic eye disease on work, 179 (45.1%) took early retirement because of visual loss related to diabetes mellitus. A total of 291 (73.3%) patients partially paid for their diabetic retinopathy treatment. The cost varied from 20 to 8000 Egyptian pounds with a mean of 630.5 Egyptian pounds. The government supported 314 (79.1%) patients. The cost varied from 300 to 8200 Egyptian pounds with a mean of 2523.41 Egyptian pounds paid by Ministry of Health and National Health Insurance. The total economic burden for treating diabetic eye disease in these patients was 975,840 Egyptian pounds: the government paid 792,350 (81.2%), while patients paid 183,490 (18.8%).

Discussion

The Wisconsin Epidemiological Study of Diabetic Retinopathy (WESDR) concluded that 3.6% of those diagnosed with type I and 1.6% of those diagnosed with type II diabetes mellitus were legally considered blind. For type I diabetes mellitus, blindness was mostly (86%) due to diabetic retinopathy. For type II, blindness was related to retinopathy in 33% of the cases.14 The annual incidence of retinopathy requiring ophthalmological follow up or treatment has been reported to average 1.5% after 1 year. Between 6% and 9% of patients with proliferative retinopathy or severe nonproliferative disease would become blind each year.15 In our study, living in urban areas was not an advantage; as 196 (49.4%) of the patients included in this study developed advanced diabetic eye disease. Our results show that patient awareness about diabetic retinopathy was low, since only 158 (39.8%) knew about the possible deleterious effect of diabetes on eyesight. This may be related to low patient education, as 140 (35.2%) were illiterate. Illiteracy may contribute to non-compliance and inefficient doctor–patient education. Low income may discourage patients from seeking medical advice. However, the result for patient awareness in the present study is higher than in other Egyptian and Indian studies which demonstrated that 14.7% and 18% of patients respectively were aware of the hazards of diabetes mellitus for the eyes.4,16 The difference may be attributed to better distribution of the patient sample through all socioeconomic classes of the Egyptian population and not only the low, illiterate one. Effective methods to deliver patient education and teach self-management skills that result in longer-term improvements to health are needed. All primary care organizations, as suggested by the Diabetes National Service Framework and the National Institute for Clinical Excellence, must offer structured educational programs to people with diabetes in order to improve glycemic control, reduce requirement for diabetes medication, improve early detection of diabetic complications, and treatment satisfaction.17–22 Multivariate logistic regression showed the importance of edication in predicting patients’ awareness about diabetic retinopathy (Odds ratio, 1.47, CI 1.092–1.99, P = 0.01). With regard to the source of information on diabetic retinopathy, our result shows that the sources were multiple and patients’ level of knowledge varied. Almost one-third of the patients acquired their knowledge through their internist, while most (391, 98.5%) chose their ophthalmologist after their visual loss. Multivariate logistic regression showed the role of the internist to be of utmost importance in predicting the awareness of patients about diabetic retinopathy with OR 156.1, CI 63.31–384.63, P < 0.001. Patients present late to the ophthalmologist, and the role of the internist in the prophylaxis, patient education, and early detection of diabetic retinopathy is crucial. Although 59 (14.9%) patients referred to other patients and 34 (8.6%) chose media as a source of information about diabetic eye disease, both sources were found to be statistically significant in promoting patients’ awareness about the sight-threatening effect of diabetes mellitus (other patients OR 8.5, CI 2.99–24.23, P < 0.001 and media OR 29.96; CI 5.57–161.26, P < 0.001, respectively). Laser photocoagulation represents the mainstay of prophylaxis against complications of diabetic retinopathy.11 In our study, only 32.7% of patients received laser treatment at the time of the survey. This study showed that the Egyptian government carried most of the direct costs of treating diabetic retinopathy. The government expenditure constituted 81.2%, while the patient’s economic burden was only 18.8%. The indirect cost could not be calculated. The main bulk of the indirect cost is lost productivity due to temporary work disability, absenteeism, early retirement, rehabilitation, and medication fee.22 In this study, 45.1% had early retirement because of visual loss related to diabetes mellitus. The strength of our study lies in the relatively large sample size of patients and the structured interview, which included much sociodemographic data besides the clinical examination. This descriptive study has included data from several referral centers representing the four main health organizations in Egypt. The following limitations have to be realized: firstly, the self-reported nature of the questionnaire is subject to informant bias; and secondly, the selection bias, which is due to exclusion of diabetic patients with normal fundus. In conclusion, this descriptive study found that illiteracy contributes to noncompliance and late presentation. The role of the internist and media in improving the awareness of patients about diabetic retinopathy is of utmost importance. A continuous medical education program with implementation of evidence-based practices and screening programs for early detection of diabetic retinopathy are essential to improve the standard of care.
  15 in total

1.  Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.

Authors:  W H Herman; R E Aubert; M M Engelgau; T J Thompson; M A Ali; E S Sous; M Hegazy; A Badran; S J Kenny; E W Gunter; A M Malarcher; R J Brechner; S F Wetterhall; F DeStefano; P J Smith; M Habib; S abd el Shakour; A S Ibrahim; E M el Behairy
Journal:  Diabet Med       Date:  1998-12       Impact factor: 4.359

2.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

3.  Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

4.  The economic impact of ophthalmic services for persons with diabetes in the Canadian Province of Nova Scotia: 1993-1996.

Authors:  A F Smith
Journal:  Ophthalmic Epidemiol       Date:  2001-02       Impact factor: 1.648

5.  Structured patient education: the diabetes X-PERT Programme makes a difference.

Authors:  T A Deakin; J E Cade; R Williams; D C Greenwood
Journal:  Diabet Med       Date:  2006-09       Impact factor: 4.359

6.  Awareness and knowledge of diabetes in Chennai--the Chennai Urban Rural Epidemiology Study [CURES-9].

Authors:  Deepa Mohan; Deepa Raj; C S Shanthirani; Manjula Datta; N C Unwin; A Kapur; V Mohan
Journal:  J Assoc Physicians India       Date:  2005-04

7.  Epidemiology of diabetic retinopathy in Egypt: a hospital-based study.

Authors:  Tamer A Macky; Noha Khater; Mohammad A Al-Zamil; Hussein El Fishawy; Mahmoud M Soliman
Journal:  Ophthalmic Res       Date:  2010-08-12       Impact factor: 2.892

8.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

9.  Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

10.  Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1979-04
View more
  2 in total

1.  Preferred Method of Education Among Patients in Ophthalmic Care in Saudi Arabia.

Authors:  Sara M AlHilali; Abdulrahman M AlMuammar; Eman AlKahtani; Rajiv Khandekar; Abdulrahman A AlJasser
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Apr-Jun

2.  Patient education preferences in ophthalmic care.

Authors:  Jullia A Rosdahl; Lakshmi Swamy; Sandra Stinnett; Kelly W Muir
Journal:  Patient Prefer Adherence       Date:  2014-04-25       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.